Physician profile
John D Dockery
NPI 1245279991
$4,713.37
in general payments reported to CMS, 2019-2025
11 companies · $646 in 2025
The $646 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2021: $442 · 2022: $1,967 · 2023: $620 · 2024: $315 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,821.39 | 2022 | |
| Abbott Laboratories | $1,516.89 | 2019-2025 | Eterna, Proclaim |
| Medtronic, INC. | $431.28 | 2021 | |
| Boston Scientific Corporation | $404.50 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Biotissue Holdings INC. | $144.60 | 2025 | |
| Ucb, INC. | $123.38 | 2022 | |
| Amgen INC. | $121.98 | 2019-2024 | Evenity, Prolia |
| Curonix LLC | $86.35 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $29.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.64 | 2025 | Exparel, Zilretta |
| Heron Therapeutics, INC. | $10.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dockery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.